학술논문

LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S1340-S1340
Subject
Language
ISSN
0923-7534